[Clinical and microbiological study regarding surface antibacterial properties of bioactive dental materials].
In the new era of dentistry the coronal restoration materials must possess "bio-active" features represented by fluor ions release, chemical adhesion and antibacterial agents.


OBJECTIVE
Our study aims to determine the surface antibacterial properties of glassionomer cements and compomers.


METHODS
The study group included 64 patients with high cariogenic risk with 80 teeth with acute and chronic dental caries affecting proximal and occlusal dental surfaces. The teeth with cariogenic lesions were restored with zinc-oxide-eugenol (n=20), glassionomer cement GC Fuji Triage (n=20), glassionomer cement modified with resins Fuji II LC (n=20), compomer Dyract (n=20). DENTOCULT SM test (Orion Diagnostica, Finland) was used for bacterial analyses. The samples from bacterial biofilm were collected from the restorated dental surfaces (study group) and intact enamel surfaces (control group). The recorded data were processed using non-parametrical statistical tests.


RESULTS
The lowest mean value of bacterial indices was recorded for glassionomer cement Fuji Triage (0.4), and Fuji II LC (1.2), material with highest surface antibacterial properties. The highest value (1.5) was recorded for compomer Dyract. The Kruskal-Wallis test proves the significant statistical differences between the three bioactive materials.


CONCLUSIONS
The materials with bioactive features have the ability to inhibate the growth of Streptococcus mutans in bacterial biofilm to the surfaces of coronal restoration.
Târcă
T
T
Universităţii de Medicină şi Farmacie Gr.T. Popa Iaşi, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi, Facultatea Medicină Dentară.
Bădescu
Aida
A
Topoliceanu
C
C
Lăcătuşu
St
S
D016022:Case-Control Studies; D020770:Compomers / Q000494:pharmacology; D003731:Dental Caries / Q000382:microbiology / Q000628:therapy*; D003738:Dental Cements / Q000494:pharmacology*; D003793:Dental Restoration, Permanent / Q000379:methods; D005899:Glass Ionomer Cements / Q000494:pharmacology; D006801:Humans; D012117:Resins, Synthetic / Q000494:pharmacology; D018709:Statistics, Nonparametric; D013295:Streptococcus mutans / Q000187:drug effects*; D013499:Surface Properties / Q000187:drug effects; D017001:Tooth Demineralization / Q000382:microbiology / Q000517:prevention & control*; D015035:Zinc Oxide-Eugenol Cement / Q000494:pharmacology
D020770:Compomers; D003738:Dental Cements; C088486:Dyract; C079765:Fuji II LC cement; D005899:Glass Ionomer Cements; D012117:Resins, Synthetic; D015035:Zinc Oxide-Eugenol Cement